Single- and multiple-dose pharmacokinetics, pharmacodynamics, and safety of apixaban in healthy Chinese subjects [Corrigendum]

• Main Authors: Cui Y (Author), Song Y (Author), Wang J (Author), Yu Z (Author), Schuster A (Author), Barrett YC (Author), Frost C (Author)
• Format: Book
• Published: Dove Medical Press, 2014-03-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Cui Y, Song Y, Wang J, et al. Clinical Pharmacology: Advances and Applications. 2013;5(1):177–184.Note that on page 182, Figure 3 should be corrected as follows, with the line for mean anti-Xa activity extended through to 72 hours post dose on Day 9, and the Day 1 plasma apixaban concentra...